Anadys Pharmaceuticals, Inc. (ANDS) – FDA
-
Anadys Pharmaceuticals (ANDS) Reports Positive Data for Setrobuvir in Phase 2b Hepatitis C Study
-
Anadys (ANDS) Completes Enrollment in ANA598
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ANDS Stock Lookup